[go: up one dir, main page]

TW201239007A - Silicon containing prepolymer and silicon-hydrogel organic material including the same - Google Patents

Silicon containing prepolymer and silicon-hydrogel organic material including the same Download PDF

Info

Publication number
TW201239007A
TW201239007A TW100109561A TW100109561A TW201239007A TW 201239007 A TW201239007 A TW 201239007A TW 100109561 A TW100109561 A TW 100109561A TW 100109561 A TW100109561 A TW 100109561A TW 201239007 A TW201239007 A TW 201239007A
Authority
TW
Taiwan
Prior art keywords
group
methyl
pentanol
hydrogel
weight
Prior art date
Application number
TW100109561A
Other languages
Chinese (zh)
Other versions
TWI418573B (en
Inventor
Chien-Ching Chan
Original Assignee
Chien-Ching Chan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chien-Ching Chan filed Critical Chien-Ching Chan
Priority to TW100109561A priority Critical patent/TWI418573B/en
Priority to CN201210044457.3A priority patent/CN102690419B/en
Priority to KR1020120026547A priority patent/KR101410005B1/en
Publication of TW201239007A publication Critical patent/TW201239007A/en
Application granted granted Critical
Publication of TWI418573B publication Critical patent/TWI418573B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive bandages or dressings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04Polysiloxanes
    • GPHYSICS
    • G02OPTICS
    • G02CSPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00Optical parts
    • G02C7/02Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04Contact lenses for the eyes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Eyeglasses (AREA)
  • Materials For Medical Uses (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

A silicon containing prepolymer represented by the following structure: wherein n1 is integer 1 to 20. A is a divalent aliphatic group or a divalent aromatic group. All Y's are identical or different. Alternatively, some Y's are identical and some Y's are different. Y is H atom or Ry is an aromatic alkyl group including fluorine atom, an ether group including fluorine atom, an ether group or an amino group. X is an oxygen atom or -NRx-, wherein Rx is a hydrogen atom or a monovalent alkyl group having 1 to 5 carbon atoms or. Ry is defined the same above. All Rx's are identical or different. Or, some Rx's are identical and some Rx's are different. Z represents a group containing C-C double bond.

Description

201239007 36950twf.doc/n 六、發明說明: 【發明所屬之技術領域】 本發明是有關於一種預聚物與水凝膠,且特別是有關 於一種含矽預聚物與聚矽酮水凝膠。 【先前技術】 水凝膠是一種水合交聯高分子,性質柔軟,能保持一 定的形狀,並且可以吸收大量的水。水凝膠通常具有透氧 性和生物適應性,因此,非常適合用來製造醫用生物材料, 例如是隱形眼鏡、眼科敷材或一般外科敷材。 傳統的水凝膠主要是以含有親水單體的混合物來製 備,例如是2-羥基乙基曱基丙烯酸酯(ΗΕΜΑμΐΝ_乙烯基 11比錢i^I(NVP)。蚊’ a些倾財轉⑽氧性仍不 足,所製成的醫材用水凝膠並不適合長時間配戴。 ^先進^水凝膠是以聚矽酮單體來製成聚矽 酮水凝 勝,其透氧性較傳統的水凝膠高,然而,聚《烟水凝膠卻 存在彈性不足’所製成的水郷無法滿足使歸舒適之需 求。 【發明内容】 本發明提供-種含石夕預聚物,其可做為聚石夕酮水凝膠 之反應物。 本發明提供-種聚石夕_水凝其具有高透與高 彈性。 201239007 本發明提出一種含矽預聚物,其結構如下式一所示: 【式一】201239007 36950twf.doc/n VI. Description of the Invention: [Technical Field] The present invention relates to a prepolymer and a hydrogel, and more particularly to a cerium-containing prepolymer and a polyfluorene ketone hydrogel. . [Prior Art] A hydrogel is a hydrated crosslinked polymer which is soft in nature, can maintain a certain shape, and can absorb a large amount of water. Hydrogels are generally oxygen permeable and biocompatible and, therefore, are well suited for use in the manufacture of medical biomaterials such as contact lenses, ophthalmic dressings or general surgical dressings. Conventional hydrogels are mainly prepared from a mixture containing a hydrophilic monomer, such as 2-hydroxyethyl decyl acrylate (ΗΕΜΑμΐΝ_vinyl 11 to money i^I (NVP). Mosquito' a bit of money (10) Oxygen is still insufficient, and the hydrogel produced by the medical material is not suitable for long-term wear. ^Advanced hydrogel is made of polyfluorenone monomer to make polyfluorene ketone water condensate, and its oxygen permeability is better. The conventional hydrogel is high, however, the water hydrazine produced by the poly "smoke hydrogel has insufficient elasticity" cannot satisfy the demand for comfort. [Invention] The present invention provides a zephyr-containing prepolymer, which It can be used as a reactant of the polysulfone hydrogel. The present invention provides a high-permeability and high elasticity of the poly-stone. The present invention provides a cerium-containing prepolymer having the following structure: Show: [Formula 1]

Z—X—E—X--C—N—A—N—C—X—E—X—Z 其中nl為1至20之整數;Α表示脂肪族基團或芳香族基 團;Y表示Η或是Z—X—E—X—C—N—A—N—C—X—E—X—Z wherein nl is an integer from 1 to 20; Α represents an aliphatic group or an aromatic group; Y represents Η Or

—C=〇 全部的Υ可以完全相同或完全相異,或是部分Υ相同且部 分Υ相異;Ry表示含氟之芳香族基團、含謎基團、含氟 之醚基團或是含胺基之基團;X表示0或是示 Η,或是碳數為1至5之一價烷基,或—C=〇All Υ may be identical or completely different, or partially Υ identical and partially Υ different; Ry represents a fluorine-containing aromatic group, a mysterious group, a fluorine-containing ether group or a group of an amine group; X represents 0 or a hydrazine, or a valence alkyl group having a carbon number of 1 to 5, or

其中Ry之定義如上;全部的Rx為完全相同或完全相異, 或是部分Rx相同且部分Rx相異;以及Z表示含烯基團。 依照本發明一實施例所述,上述A所表示的兩價脂肪 族基團或芳香族基團的碳數為1至20 ; E所表示二價矽氧 烧基,其結構如下式二所示: 【式二】Wherein Ry is as defined above; all Rx are identical or completely different, or part of Rx is the same and part of Rx is different; and Z represents an alkenyl group. According to an embodiment of the present invention, the carbon number of the divalent aliphatic group or the aromatic group represented by the above A is from 1 to 20; wherein the E represents a divalent anthracene group, and the structure thereof is as shown in the following formula 2 : [Formula 2]

201239007 36950twf.doc/n 其中Rei與ReZ各自分別表示氫、碳數為1至5的一價燒 基、含氟取代基的院基或醚基;Rei與Re2可以相同或是相 異;m為0至40之整數;Q表示碳數為1至10之直鏈或 支鏈之二價烧基;L表示單鍵、_基或燒醇基;z之結構 如下式三所示: 【式三】 C— N—CH2CH2—201239007 36950twf.doc/n wherein Rei and ReZ each represent hydrogen, a monovalent alkyl group having a carbon number of 1 to 5, a hospital group or an ether group of a fluorine-containing substituent; Rei and Re2 may be the same or different; m is An integer from 0 to 40; Q represents a linear or branched divalent alkyl group having a carbon number of 1 to 10; L represents a single bond, a benzyl group or an alkoxy group; and the structure of z is as shown in the following formula 3: 】 C— N—CH2CH2—

其中Rz表示氫或是碳數為1至5之一價烧基;以及n3表 示0至5之整數。 依照本發明一實施例所述,上述L之結構如下所示 +CnH2nO 七2 其中0與Q鍵結;n為i至10之整數;以及n2為〇至2〇 之整數。 本發明還提出一種聚矽酮水凝膠之生物材料,其係由 上述之含矽預聚物之反應混合物製成,其中反應混合物還 ^括起始劑,且選擇性更進一步包括含聚矽酮單體、親水 單體、稀釋劑或其組合。 依照本發明一實施例所述,上述含矽預聚物與上述 聚石夕_單體的重量比為1 : 0至1 : 99。 依照本例—實施綱述,上述切職物與 聚矽酮單體的含量和為5至99重量%、上 、 量為5至9〇重量%、上述稀釋劑的含量為q、至7 = = 3 201239007 36950twf.doc/n 以及上述起始劑的含量為〇·〇5至5重量%,以上述反應混 合物為100重量%來計算。 依照本發明一實施例所述,上述含聚矽酮單體包括3-曱基丙烯醯基氧丙基三(三曱基矽氧烷基)矽烷(TRIS)、丙 烯醯氧乙基苯基四甲基二矽氧烷 (phenyltetramethyldisiloxanylethyl acrylate)、曱基丙稀醯氧 甲基五甲基二石夕氧炫(pentamethyldisiloxanylmethyl methacrylate)、甲基丙烯醯氧甲基正戊基六曱基三矽氧烧 (n-pentylhexamethyltrisiloxanylmethyl methacrylate)、七甲 基丙烯酿氧乙基三石夕氧烧(heptamethyltrisiloxanylethy acrylate)、丙烯醯氧乙基三異丙基四曱基三矽氧烷 (tri-i-propyltetramethyltrisiloxanylethyl acrylate )、曱基丙 烯醯氧乙基正丙基八甲基四矽氧烷 (n-propyloctamethyltetrasiloxanylpropyl methacrylate)、曱基 丙烯醯氧曱基二(三曱基矽氧基)曱基矽烷 (methyldi(trimethylsiloxy)_methacryloxymethylsilane )、丙 烯醯氧曱基三苯基二甲基二矽氧烷 (triphenyldimethyldisiloxanylmethyl acrylate)、丙烯醯氧乙 基苯基四乙基二石夕氧烧(phenyltetraethyldisiloxanylethyl methacrylate )、丙婦醯氧甲基異丁基六曱基三石夕氧烧 (isobutylhexamethyltrisiloxanylmethyl methacrylate)或丙稀 醯氧乙基異丁基四曱基二矽氧烷 (t-butyltetramethyldisiloxanylethyl acrylate)。 依照本發明一實施例所述,上述親水單體包括N,N- 201239007 36950twf.doc/n 二甲基丙烯醯胺(DMA)、2-羥基乙基甲基兩 (HEMA)、甲基丙烯酸甘油酯、2 夂曰 r—』(NVP)'聚酿胺甲 基丙烯酸、丙烯酸或其組合。 3甲 依,本發明—實施例所述,上述稀釋劑包括乙醇、^ 丙%、異丙醇、丁醇、異丁醇、2_丁醇、2_甲基 醇、2-戊醇、3_戊醇、3_甲基丁醇、3_甲基·2、丁醇:〜: 土 _ _丁醇、2-甲基丁醇、丨_己醇、2_己醇、3•己 戊醇、3-甲基小戊醇、"基+戊醇、2·甲基_2: 甲:;3:甲基戊醇、4_甲基戊醇、2-甲基·3'戊醇""、3-土 y戊醇、3,3-二甲基丁醇、2_乙基小丁醇' 卜庵 2_庚醇'3_庚醇' 4_庚醇、l辛醇、i•壬醇或其組合。/、 依照本發明—實施例所述,上述起始劑包括2°#_其 :基广苯基小丙酮、雙(2,4,6_三甲基苯甲醯基)_苯二化 膦、1-羥基環己基苯基丙酮、2·(2 土氧化 =化膦、2,2-二甲氧基-苯(基乙二 == )過氧化本、過氧化新戍酸叔丁醋、偶 過乳化十二醯或過氧化(2_乙基己酸)叔丁醋。異庚晴 材料實施例所述’上述聚梦酮水凝勝之生物 =係將上述反應混合物照光或是加熱聚合而成或其組 材料施例所述,上述聚㈣水凝膠之生物 敷材γ y ^艮科敷材、一般外科敷材或智慧型藥物Wherein Rz represents hydrogen or a carbon number of 1 to 5; and n3 represents an integer of 0 to 5. According to an embodiment of the invention, the structure of the above L is as follows: +CnH2nO 七 2 wherein 0 and Q are bonded; n is an integer from i to 10; and n2 is an integer from 〇 to 2〇. The present invention also provides a biomaterial of a polyfluorene ketone hydrogel prepared from the above reaction mixture containing a ruthenium prepolymer, wherein the reaction mixture further comprises an initiator, and the selectivity further comprises polyfluorene. A ketone monomer, a hydrophilic monomer, a diluent, or a combination thereof. According to an embodiment of the invention, the weight ratio of the cerium-containing prepolymer to the poly-stone monomer is from 1:0 to 1:99. According to the embodiment-implementation, the content of the above-mentioned excision and the polyketone monomer is 5 to 99% by weight, the upper amount is 5 to 9% by weight, and the content of the above diluent is q to 7 = = 3 201239007 36950twf.doc/n and the above-mentioned initiator are contained in an amount of 5 to 5% by weight, based on 100% by weight of the above reaction mixture. According to an embodiment of the invention, the polyketone-containing monomer comprises 3-mercaptopropenyloxypropyltris(trimethylsulfonyloxyalkyl)decane (TRIS), propylene oxiranyl phenyl tetra Phenyltetramethyldisiloxanylethyl acrylate, pentamethyldisiloxanylmethyl methacrylate, methacryloyloxymethyl-n-pentyl hexamethylenetrioxane N-pentylhexamethyltrisiloxanylmethyl methacrylate), heptamethyltrisiloxanylethy acrylate, tri-i-propyltetramethyltrisiloxanylethyl acrylate, fluorenyl N-propyloctamethyltetrasiloxanylpropyl methacrylate, methyldi(trimethylsiloxy)_methacryloxymethylsilane, propylene Triphenyldimethyldisiloxanylmethyl acrylate, propylene oxyethyl phenyl tetraethyl lithium Phenyltetraethyldisiloxanylethyl methacrylate, isobutylhexamethyltrisiloxanylmethyl methacrylate or t-butyltetramethyldisiloxanylethyl acrylate ). According to an embodiment of the invention, the hydrophilic monomer comprises N, N-201239007 36950twf.doc/n dimethyl methacrylate (DMA), 2-hydroxyethyl methyl two (HEMA), glycerol methacrylate Ester, 2 夂曰r-』(NVP)' polystyrene methacrylic acid, acrylic acid or a combination thereof. 3, according to the invention - the examples, the above diluents include ethanol, propylene, isopropanol, butanol, isobutanol, 2-butanol, 2-methyl alcohol, 2-pentanol, 3 _Pentanol, 3-methylbutanol, 3-methyl-2, butanol: ~: soil _ _butanol, 2-methylbutanol, 丨-hexanol, 2-hexanol, 3·hexan Alcohol, 3-methyl pentanol, "yl+pentanol, 2·methyl_2: A:; 3: methylpentanol, 4-methylpentanol, 2-methyl·3'pentanol "", 3- soil y-pentanol, 3,3-dimethylbutanol, 2-ethyl butylbutanol's diterpene 2_heptanol '3-heptanol' 4_heptanol, l octanol , i• sterol or a combination thereof. /, according to the present invention - the examples, the above starting agent comprises 2 ° #_: gibberyl phenyl small acetone, bis (2,4,6-trimethylbenzylidene) benzene phosphine oxide , 1-hydroxycyclohexylphenylacetone, 2·(2 earth oxide = phosphine, 2,2-dimethoxy-benzene (ylethylene ==) peroxidation, peroxidic neodecanoic acid t-butyl vinegar, Even over-emulsified twelfth or peroxidized (2-ethylhexanoic acid) t-butyl vinegar. The above-mentioned polymunone hydrolyzed organisms as described in the example of the hexanyl sulphate material = illuminating or heating the above reaction mixture Or the material of the above-mentioned poly(tetra) hydrogel, γ y ^ 艮 敷, general surgical dressing or intelligent medicine

S 8 201239007 36950twf.doc/n 本發明實施例之含矽預聚物,其可做為聚矽酮水凝膠 之反應物。 本發明實施例之聚矽酮水凝膠,其具有高透氧性與高 彈性。 〃 為讓本發明之上述特徵和優點能更明顯易懂,下文特 舉實施例,並配合所附圖式作詳細說明如下。 【實施方式】 本發明提出一種含石夕預聚物,其結構如下式一所示: 【式一】S 8 201239007 36950 twf.doc/n A cerium-containing prepolymer of the present invention, which can be used as a reactant for a polyfluorenone hydrogel. The polyfluorene ketone hydrogel of the embodiment of the invention has high oxygen permeability and high elasticity. The above described features and advantages of the present invention will become more apparent from the following description. [Embodiment] The present invention provides a stone-containing prepolymer having a structure as shown in the following formula 1: [Formula 1]

γ Y 2 X— E X- - C—N—A— N 一 C—X— E-X- -- ^ Ο Ο n1 A表示碳數為1至20的兩價脂肪族基團或芳香族基團。脂 肪族基團可以是直鏈亞烷基、支鏈亞烷基、環烷基或兩價 酮基,例如是亞丙基、亞丁基、亞戊基、亞己基、亞庚基、 亞辛基或異佛爾酮基(isophoronyl group)。芳香族基團例如 是兩價芳烷基,例如是二苯曱烷基或曱苯基。 在任一實施例中,全部的γ可以完全相同或完全相 異,或是部分Y相同且部分Y相異。在一實施例中,丫表 示氫(H)。在另一實施例中,γ可以下化學式表示 r|i—η —c=o ,其中Ry表示含氟之芳香族基團、含醚基團、含氟之醚 201239007 36950twf.doc/n 基團或含胺基之基團。Ry中含氟,可以降低所形成之人石 預聚物的酯質沾黏性。含氟之芳香族基團例如是2•氟/ = 氟曱基)笨基或2-氟_5-(曱基)苯基。Ry為含_基圑或含胺 基之基團,可以提高所形成之含矽預聚物的親水性。^醚 基團例如聚乙二醇基(PEG)、聚丙二醇基(ppG)或聚乙二醇 /聚丙二醇基之共聚合物(PEG/PPG copolymer)。含胺基之基 團例如是聚乙烯吡咯烷晒基(PVP)或聚N,N-二曱基丙烯醯 胺基(poly-DMA)。Ry為含氟之醚基團,可以提高所形成之 含矽預聚物的親水性’也可以降低所形成之含矽預聚物的 酯質沾黏性,例如是Ν,Ν·二曱基-(2-異佛爾酮)丙胺基2,2,3,3-四氟丙鍵基或Ν,Ν-二甲基-(2-異佛爾g同)丙胺基2,2,3,3,4,4,5,5-八氟戊醚基,其結構如下所示:γ Y 2 X— E X- — C—N—A—N—C—X—E—X— -- ^ Ο Ο n1 A represents a divalent aliphatic group or an aromatic group having a carbon number of 1 to 20. The aliphatic group may be a linear alkylene group, a branched alkylene group, a cycloalkyl group or a divalent ketone group, for example, a propylene group, a butylene group, a pentylene group, a hexylene group, a heptylene group, an octylene group. Or isophoronyl group. The aromatic group is, for example, a divalent aralkyl group such as a diphenyl fluorenyl group or a fluorenyl phenyl group. In either embodiment, all of the gamma may be identical or completely different, or the portions Y may be the same and the portion Y may be different. In one embodiment, hydrazine represents hydrogen (H). In another embodiment, γ can be represented by the formula: r|i—η—c=o, wherein Ry represents a fluorine-containing aromatic group, an ether group, and a fluorine-containing ether 201239007 36950twf.doc/n group Or an amine group-containing group. Fluorine in Ry can reduce the ester viscosity of the formed human stone prepolymer. The fluorine-containing aromatic group is, for example, 2•fluoro/=fluoroindolyl or 2-fluoro-5-(indenyl)phenyl. Ry is a group containing a fluorenyl group or an amine group, and the hydrophilicity of the formed cerium-containing prepolymer can be improved. ^ Ether groups such as polyethylene glycol based (PEG), polypropylene glycol based (ppG) or polyethylene glycol / polypropylene glycol based copolymers (PEG / PPG copolymer). The amino group-containing group is, for example, polyvinylpyrrolidone (PVP) or poly N,N-dimercaptopropenylamine (poly-DMA). Ry is a fluorine-containing ether group, which can improve the hydrophilicity of the formed cerium-containing prepolymer, and can also lower the ester-based viscosity of the formed cerium-containing prepolymer, for example, ruthenium, ruthenium and decyl. -(2-Isophorone) propylamino 2,2,3,3-tetrafluoropropyl bond or oxime, Ν-dimethyl-(2-isophor g) propylamine 2,2,3, 3,4,4,5,5-octafluoropentyl ether group, the structure of which is as follows:

X表示Ο或是-NRX-,在任一實施例中,全部的Rx可 以完全相同或是完全相異’或是部分相同且部分心相 異。其例如是,Rx表示Η,或是碳數為1至5之一價烷基, 例如是曱基或乙基’或是 201239007 36950twf.doc/n I|J—Η —C=0 , 其中Ry之定義如上,於此不再贅述。 E為具有下列結構之二價矽氧烷基,其結構如下式二 所示: 【式二】 fj^el Si——Q—Ir ^e1 —L·—Q-(-Si一Ο-X represents Ο or -NRX-, and in any embodiment, all Rx may be identical or completely different' or partially identical and partially different. For example, Rx represents hydrazine or a monovalent alkyl group having a carbon number of 1 to 5, such as fluorenyl or ethyl' or 201239007 36950 twf.doc/n I|J-Η-C=0, wherein Ry The definition is as above, and will not be described here. E is a divalent oxiranyl group having the following structure, and its structure is as shown in the following formula 2: [Formula 2] fj^el Si——Q-Ir ^e1 —L·—Q-(-Si-Ο-

Re2 Re2Re2 Re2

Rei與Re2各自分別表示氫,或是碳數為1至5的一價 烷基、含氟取代基的烷基或醚基。Rel與Re2可以相同或是 相異。m為0至40之整數,較佳的是3至35之整數,更 佳的是5至30之整數。Q表示碳數為1至1〇之直鏈或支 鏈之二價烧基。L表示單鍵(direct bond)、醚基或烧醇基。 在一實施例中’醚基可以是烷二醇基(alkylene glycol group),其可表示為 χ2 其中氧與Q鍵結。η為1至10之整數,較佳的是2至8 之整數。η2為〇至2〇之整數,較佳的是0至18之整數, 更佳的是〇至15之整數。 nl為1至20之整數,較佳的是1至12之整數,更佳 的是1至6之整數。 Z表示為具有下列化學式之含烯基團,係作為前述含 石夕預聚物後續製備生醫材料之反應端點,其結構如下式三 201239007 36950twf.doc/n 所示: 【式三】 Ο Η Ο —(-C— N—CH2CH2-〇-^C-C^Rz η ch2 其中Rz表示氫’或是碳數為1至5之一價烷基,例如是甲 基或乙基。n3表示〇到5的整數。 用以製作上述含矽預聚物的反應物包括: 0=C=N-A-N = C=Ο HO-E-OH 或 NH2_E-NH2 以及 Ο Ο 〇=c=n—ch2ch2-〇—c—c/Rz 或 ci—έ—c/Rz w w ch2 ch2 其中A、E以及Rz之定義如上所述。 0 = C = N-A-N=C = 0之脂肪族的實例包括異佛爾酮 二異氰酸自旨、1,3-丙二異氰酸 g 旨(l,3-diisocyanatopropane)、 1,8-辛二異氰酸酯(l,8-diisocyanatooctane)、1,5-戊二異氰酸 酯(l,5-diisocyanatopentane) 、1,6-己二異氰酸酯 (1,6-diisocyanatohexane) 、 1,4- 丁二異氰酸酯 (l,4-diisocyanatobutane)或異環己醯亞胺。較佳的是ι,4-丁 二異氰酸酯或異環己醯亞胺。0=C = N-A-N=C = 〇之芳 香族之實例包括二異氰酸二苯曱烷或二異氰酸曱苯。Rei and Re2 each represent hydrogen, respectively, or a monovalent alkyl group having a carbon number of 1 to 5, an alkyl group or an ether group having a fluorine-containing substituent. Rel and Re2 can be the same or different. m is an integer of 0 to 40, preferably an integer of 3 to 35, more preferably an integer of 5 to 30. Q represents a linear or branched divalent alkyl group having a carbon number of 1 to 1 Å. L represents a direct bond, an ether group or an alkoxy group. In one embodiment the 'ether group' may be an alkylene glycol group, which may be represented by χ2 wherein oxygen is bonded to Q. η is an integer of 1 to 10, preferably an integer of 2 to 8. Η2 is an integer from 〇 to 2〇, preferably an integer from 0 to 18, more preferably an integer from 〇 to 15. Nl is an integer of 1 to 20, preferably an integer of 1 to 12, more preferably an integer of 1 to 6. Z is represented by an alkenyl group having the following chemical formula, and is used as a reaction end point of the above-mentioned preparation of a biomedical material containing the shixi prepolymer, and its structure is as shown in the following formula 3: 200339007 36950 twf.doc/n: [Formula 3] Ο Η Ο —(-C—N—CH2CH2-〇-^CC^Rz η ch2 wherein Rz represents hydrogen' or a monovalent alkyl group having a carbon number of 1 to 5, such as methyl or ethyl. An integer of 5. The reactants used to prepare the above-described cerium-containing prepolymer include: 0=C=NAN = C=Ο HO-E-OH or NH2_E-NH2 and Ο Ο 〇=c=n-ch2ch2-〇-c —c/Rz or ci—έ—c/Rz ww ch2 ch2 wherein A, E and Rz are as defined above. 0 = C = NAN=C = 0 Examples of aliphatics include isophorone diisocyanate Self-acting, 1,3-propanediisocyanate g (l,3-diisocyanatopropane), 1,8-octane diisocyanate (1,8-diisocyanatooctane), 1,5-pentane diisocyanate (l,5-diisocyanatopentane , 1,6-diisocyanatohexane, 1,4-butane diisocyanate (1,4-diisocyanatobutane) or isocyclohexylimine. Preferred is i,4-butyl diisocyanate Or hetero ring (PEI) .0 = C = N-A-N = C = examples of aromatic incense square of aromatic diisocyanates include diphenylmethane diisocyanate Yue Yue alkyl or phenyl.

S 12 201239007 36950twf.doc/n HO-E-OH的實例包括兩末端為羥基烷基的聚二曱基 i石夕氧烧(Poly(dimethylsiloxane),bis(hydroxyalkyl) terminated),例如: CH3 ch3 ch3Examples of S 12 201239007 36950twf.doc/n HO-E-OH include poly(dimethylsiloxane), bis(hydroxyalkyl) terminated, for example: CH3 ch3 ch3

I [I 1 II [I 1 I

H〇-H2CH2CH2C-Si—〇一Si——〇-—Si_CH2CH2CH2-〇H CH3 ch3 70 ch3 ch3 ch3 ch3H〇-H2CH2CH2C-Si—〇一Si——〇——Si_CH2CH2CH2-〇H CH3 ch3 70 ch3 ch3 ch3 ch3

I [I 1 II [I 1 I

H〇-H2CH2CH2C-Si-〇一一Si——〇—Si-CH2CH2CH2-〇H ch3 ch3 14ch3 或聚醚矽氧烷二元醇 (polyethyleneoxide-b-dimethylsiloxane-polyethylenoxide ) ,例如: CH, CH, ho-h2ch2co- 15 H2CH2CH2O—Si—0—S 卜 CH2CH2CH2. och2ch2- -0H 15 ch3 ch3 NH2-E-NH2實例包括兩末端為胺基炼基的聚二曱基矽 V.,· · V …、··* .VV〆·、,.'vV..:.,、八....*V >.、、'..· . : . J ' . . w'., · ^ -*· V .、 ->,、··,、、 . - · ' V - ' 氧烧(Poly(dimethylsiloxane), bis(3-aminoalkyl)terminatec〇,例 13 201239007 36950twf.doc/n ch3 ch3 H2N-H2CH2CH2C-Si-〇·H〇-H2CH2CH2C-Si-〇-Si-〇-Si-CH2CH2CH2-〇H ch3 ch3 14ch3 or polyoxide oxide-b-dimethylsiloxane-polyethylenoxide, for example: CH, CH, ho -h2ch2co- 15 H2CH2CH2O-Si-0-S 卜CH2CH2CH2. och2ch2- -0H 15 ch3 ch3 Examples of NH2-E-NH2 include polydifluorenyl ruthenium V., · V ..., ·* .VV〆·,,.'vV..:.,,8....*V >.,,..·. . : . J ' . . w'., · ^ -*· V ., ->,,··,,, . - · 'V - 'Oxygen (Poly(dimethylsiloxane), bis(3-aminoalkyl)terminatec〇,Example 13 201239007 36950twf.doc/n ch3 ch3 H2N-H2CH2CH2C- Si-〇·

Si一0· CH3 ch3 20 ch3Si-CH2CH2CH2-NH2 ch3 CH' ch3 ch3 H2N-H2CH2CH2C-Si-〇-Si-0·CH3 ch3 20 ch3Si-CH2CH2CH2-NH2 ch3 CH' ch3 ch3 H2N-H2CH2CH2C-Si-〇-

Si—0- •Si-CH2CH2CH2~NH^ CH, CH3 ch3 0=C=N—CH2CH2-〇- I? /Rz ch2 或 Cl—c— ch2 的實例包括曱基丙烯酸異氰酸基乙酯、丙烯酸異氰酸基乙 酯、甲基丙稀醢氯或丙稀醯氯。較佳的是曱基丙烯酸異氛 酸基乙酯或曱基丙烯醯氯。 當上述含矽預聚物的Y表示Η時,在一實施例中, 上述含矽預聚物的合成方法係將適當比例之上述三種成 分,例如是 0 = C=N-A-N=C=0 : HO-E-OH 或 NH2-E-NH2 : 〇 或 a— CH2 ΟExamples of Si—0— •Si—CH 2 CH 2 CH 2 —NH ^ CH, CH 3 ch 3 0=C=N—CH 2 CH 2 ——— I? /Rz ch 2 or Cl—c— ch 2 include isocyanatoethyl acrylate, acrylic acid Isocyanatoethyl ester, methyl propyl chloride or acrylonitrile chloride. Preferred are methacrylic acid isophthalic acid ethyl ester or mercapto acrylonitrile chloride. When Y of the above-mentioned cerium-containing prepolymer represents cerium, in one embodiment, the above-mentioned cerium-containing prepolymer is synthesized in such a manner that the above three components are in an appropriate ratio, for example, 0 = C = NAN = C = 0: HO -E-OH or NH2-E-NH2 : 〇 or a- CH2 Ο

II RII R

〇=C=N—CH2CH2—〇-C一.C〆 Z ch2 以莫耳比等於 1 : 2 : 2、2 : 3 : 2、3 : 4 : 2、2.5 : 3.5 : 2、 4 : 5 : 2、3.5 : 4.5 : 2或5 : 6 : 2分別以稀釋劑稀釋後加 入反應容器中,稀釋劑例如是四氫呋喃、甲苯、N,N_二甲 基乙醯胺或其組合。之後,加入催化劑,例如是有機錫, 如2-乙基己酸錫、二月桂酸二丁基錫、油酸錫或二丁基錫 201239007 36950twf.doc/n 二-2-乙基己酸鹽;或三級胺,如三乙基胺、二甲基乙醇胺、 四曱基丁烷二胺、二曱基環己胺或1,4-重氮二環(2,2,2)辛 烧’於適當的溫度例如是45°C〜150°C反應製得15在另一 實施例中,其亦可以先將Ο = C = N_A-N = C = 〇與 ΗΟ-Ε-ΟΗ(或ΝΗ2-Ε-ΝΗ2)先以2 : 3的莫耳比進行反應之 後,再加入適量比例之 0=C=N—CH2CH2-〇 進行反應。〇=C=N—CH2CH2—〇-C一.C〆Z ch2 with molar ratio equal to 1: 2 : 2, 2 : 3 : 2, 3 : 4 : 2, 2.5 : 3.5 : 2, 4 : 5 : 2, 3.5 : 4.5 : 2 or 5 : 6 : 2 are diluted with a diluent and added to the reaction vessel, for example, tetrahydrofuran, toluene, N,N-dimethylacetamide or a combination thereof. Thereafter, a catalyst such as an organotin such as tin 2-ethylhexanoate, dibutyltin dilaurate, tin oleate or dibutyltin 201239007 36950twf.doc/n di-2-ethylhexanoate; or tertiary An amine such as triethylamine, dimethylethanolamine, tetradecylbutanediamine, dinonylcyclohexylamine or 1,4-diazobicyclo(2,2,2) octyl" at a suitable temperature For example, the reaction is carried out at 45 ° C to 150 ° C. In another embodiment, it is also possible to first Ο = C = N_A-N = C = 〇 and ΗΟ-Ε-ΟΗ (or ΝΗ2-Ε-ΝΗ2) After reacting with a molar ratio of 2:3, an appropriate amount of 0=C=N-CH2CH2-〇 is added to carry out the reaction.

0 II ^ c—Q0 II ^ c—Q

Rz ch2 或 Cl_^_c/Rz \\ ch2 當上述含矽預聚物的γ表示 Ν-Η —c=〇 (Ry之定義如上)時,則可以將上述方法所製得的含 ^ 物(γ表示H)與Ry-N=C=0反應,以進行改質。預聚 的實例包括聚乙二醇甲醚異氰酸鹽、2-氟_5_(三 基異氰酸鹽、2_氟_5_(甲基)苯基異氰酸鹽 '聚乙^笨 二醇共聚合物異氰酸鹽、聚丙二醇異氰酸鹽、聚2醇^聚丙 烷酮異氰酸鹽、聚N,N-二曱基丙烯醯胺異氰峻鹽、=比咯 曱基-(2-異佛爾鲷異氰酸酯基)丙胺基2,2,3,3_四氣’&一 顺-二曱基仏異佛爾_異氰酸醋基)丙胺基2,2,3,3 4 4基喊或 氟戊基醚。N,N_二甲基_(2-異佛爾酮異氰酸酯基j ’5,=八 2,2,3,3-四氟丙基醚與N,N-二甲基-(2-異佛爾g同異氰萨=胺基 胺基2,2,3,3,4,4,5,5_八氟戊基醚之結構如下所示:曰基)丙 15 201239007 36950twf.doc/nRz ch2 or Cl_^_c/Rz \\ ch2 When γ of the above ruthenium-containing prepolymer represents Ν-Η-c=〇 (Ry is as defined above), the content (γ) obtained by the above method can be used. Represents H) reacting with Ry-N=C=0 for upgrading. Examples of the prepolymerization include polyethylene glycol methyl ether isocyanate, 2-fluoro-5-(trisyl isocyanate, 2-fluoro-5-(methyl)phenyl isocyanate' polyethyl bromide Alcohol copolymer isocyanate, polypropylene glycol isocyanate, poly-2-olpropane ketone isocyanate, poly N,N-dimercapto acrylamide isocyanide salt, = bromo fluorenyl- (2-isophorol isocyanate) propylamino 2,2,3,3_tetraki'&-cis-dimercaptopurine oxime-isocyanate propylamine 2,2,3, 3 4 4 base shout or fluoropentyl ether. N,N-dimethyl-(2-isophorone isocyanate group j '5,=八2,2,3,3-tetrafluoropropyl ether and N,N-dimethyl-(2-isofoam) The structure of g-isocyside = aminoamine 2,2,3,3,4,4,5,5-octafluoropentyl ether is as follows: mercapto) C 15 201239007 36950twf.doc/n

較佳的是聚乙二醇甲醚異氰酸鹽或聚乙烯吡咯烷酮異氰酸 鹽。 、 上述含矽預聚物可以與其他成份反應製成各種聚矽 酮水凝膠。前述之聚矽酮水凝膠的製造方法可以將上述含 矽預聚物做為反應物,透過起始劑進行聚合反應,之後再 進行固化。含有上述含矽預聚物的反應混合物中適量的添 加含聚_單體’以有效織水_之錄倾透氣性, 並提高各單體間之相容性。此外,反應混合物中還可以選 擇性更進-步包滅水單體、交麵、稀釋劑或其組合。 反應混合物巾,含㈣聚物與含聚補單體的含量和是反 應,合物總重量的5至99重量%,較佳的是的1〇至9〇 重量/6,更佳的疋的15至80重量%。含矽預聚物與含聚 石^綱單體的重量比可以是丨:G至丨·· 99。親水單體的含量 是反^混合物總重量的5至9〇重量%,較佳的是的15至 70重量%,更佳的是的2G至5G重量%。交賴的含量是 ^應混合物總重量的〇至5重量%,較佳的㈣G至3重 里% ’更佳的是的0至2重量%。稀釋劑的含量是反應混 201239007 j〇y)utwt.doc/n 合物總重量的〇至8〇 更佳的是的0至35重& 德較的G至5G重量%’ 含聚石夕酮單體的含量^ %在一實施例中,含石夕預聚物與 為30至4〇重^ 40重量%、親水單體的含量 起始劑的含ί二1=量為…罐以及 量%來計算。 直罝^,以反應混合物為100重 上述含聚碎_單體盘卜 ^基丙_基氧丙基1 預聚物不同,其包括3- 稀醯氧乙基苯基四?2;$夕^基)石夕烧闺)' 丙 基二石夕氧烧、甲基 =、甲基丙烯醯氧甲基五甲 七甲基丙_氧^3=基正戊基Μ基三魏烧、 甲基三石夕氧烧、甲Α说酼t两稀醯氧乙基三異丙基四 ^ ^ 土丙烯醯氧乙基正丙基八甲基四矽氧 & '甲基丙_氧甲基二(三甲 = 醯氧甲某二笑其" 礼丞丞矽烷丙烯 義-石甲基二石夕減、丙稀醯氧乙基苯基四乙 酿氧甲基異丁基六甲基三彻或丙締 醞氧乙基異丁基四甲基二矽氧烷。 上述親水單體可以是任何現有技術中公開用於製造 水凝膠聚合物之親水單體。用於製造本發明聚御同水凝膠 之生物材料的親水單體可以是含乙雜或是丙稀。親水單 體包括取-二曱基丙婦醯胺(DMA)、2-經基乙基曱基丙烯 酸酯(HEMA)、甲基丙烯酸甘油酯、2-羥基乙基曱丙烯醯 胺、N-乙烯基吡咯烷酮(NVP)、聚一曱基丙烯酸乙二醇酯、 曱基丙烯酸、丙烯酸或其組合。 反應混合物可以依據聚合反應的起始劑選擇以加熱 17 201239007 36950twt.doc/n 催 m外光或其組合或其他方法來誘發聚合反應 化Μ例如是可以在中高溫下’例如是攝氏饥至⑼ 產生游離基者,例如是偶氮二異丁腈(Α贿)、過氧化 ,氧化新戊酸叔丁酯、偶氮二異庚晴、過氧化十二酿或過 氧化(2-乙基己酸)叔丁醋。#反應混合物是以紫外光來 發聚合反應時,起始劑可以是光誘發起始劑,包括2_經基 •2-甲基-1-苯基_丨_丙酮、雙(2,4,6_三甲基苯甲醯基广苯基^ 化,、1-羥基環己基苯基丙酮、2_(2,4,6_三甲基苯甲醯基) 二苯基氧化膦或2,2-二甲氧基-苯基乙嗣。 土 稀釋劑包括乙醇、1-丙醇、異丙醇、丨_丁醇、異丁醇、 2-丁醇、2-甲基-2·丙醇、1-戊醇、2-戊醇、3-戊醇、3_甲基 丁醇、3-甲基-2-丁醇' 2-甲基-2-丁醇、2-甲基丁醇、= 醇、2-己醇、3-己醇、2-曱基-1-戊醇、3-曱基-i_戊醇、4_ 甲基-1-戊醇、2-甲基-2-戊醇、3-甲基-2-戊醇、4-曱基-2- 戊醇、2-甲基-3-戊醇、3-甲基-3-戊醇、3,3-二曱基-i_丁醇、 2-乙基-1-丁醇、ι_庚醇、2_庚醇、3-庚醇、4-庚醇、1·辛醇、 1-壬醇或其組合。 除了上述的含發預聚物、含聚碎_單體、起始劑、親 水單體以及稀釋劑之外,用以製造本發明之聚石夕g同水凝膠 之生物材料的反應混合物中,還可以包括其他的單體(如紫 外線吸收單體)、反應性顏料、非反應性顏料或其組合。另 外,反應混合物中也可以包括處理助劑,例如脫模劑或濕 潤劑。 在進行反應形成聚合物之後’以溶劑去除稀釋劑以及 201239007 36950twf.doc/n 沒有反應的各種成分,再將所形成的聚合物水合,以形成 水凝膠。製造水凝膠所使用的溶劑可以是水或者是生理食 鹽水’或者可以先依據製造聚合物時所使㈣稀釋劑的溶 解度特性以及沒有反應的各種成分的溶解度特性選擇適當 的有機溶劑’例如是乙醇、曱醇、異丙醇或前述溶劑與^ 之混合物,再輯水或生理食鹽水萃取,以Μ造用水溶張 的聚石夕酮水凝膠。聚㈣水凝膠中的含水量為聚稍水凝 膠總重量的20至70重量%,較佳的是25至幻重量%, 更佳的是30至50重量%。 上述聚石夕酮水凝膠可以製成各種生物材料,例如是隱 形眼鏡、眼科敷材、-般外科敷材(眼科以外之外科敷材^ 或智慧型_敷材。聚棚水凝膠可以透過各種已知的方 法來形成所需的形狀’例如是旋轉模注法或是模注法。 例1 :含矽預聚物之合成 ' 取〇‘5莫耳雙氫氧基聚二甲基石夕氧院(PDMS di〇1)以 4A分子筛除水24小時。之後,將除水後之雙氫氧基聚二 甲基石夕氧烧置於四孔反應瓶中,並以四氫咬喃稀釋 10倍。 …、:後,加人0.4莫耳二異氰酸甲苯與〇2莫耳甲基丙稀酸 異氰基乙醋,通氮氣攪拌3〇分鐘。接著,加人總重之〇 5 重量%的2-乙基己酸錫。以6〇t油浴,則、時,再 以旋轉濃賴絲㈣,得微黃㈣液體。讀,再以筑 真空烘箱除去低揮發性物質。 例2 :含矽預聚物之合成 取〇.3莫耳雙氫氧基聚二甲基石夕氧燒(PDMS_di〇1)以 19 201239007 36950twf.doc/n 氧烧置於四孔&^、時。將除水後之雙氫氧絲二甲基石夕 ,w瓶中,並以四氫呋喃稀釋10倍。之後, M_T二異氰酸3旨與G.2莫耳甲基丙烯酸異氰 =曰其3氣攪拌30分鐘。接著,加入總重之05重量 錫。以6叱油浴,攪拌48小時,再以旋轉 Ϊ,得微黃透明液體。之後,再以5G°C真空烘箱 除去低揮發性物質。 例3 :含矽預聚物之改質 取上述,2之含石夕預聚物〇1莫耳置於四孔反應瓶 ’一並尸以四氫吱喃稀釋1()倍。之後,加人_莫耳2氣 5·(三氟甲基)苯基異氰酸鹽,通氮氣攪拌3〇分鐘。接著, 加入總重之G.5重量%二月桂酸二了基錫。贼油浴授 拌48小時後,以旋轉濃縮機濃縮,再以5〇<3(:真空烘 去低揮發性物質。 " 例4 :含矽預聚物之改質 取上述例1之含矽預聚物0.005莫耳置於四孔反應瓶 中,並以四氫呋喃稀釋10倍。之後,加入〇 〇〇5莫耳聚乙 二醇甲醚異氰酸鹽(MW:〜750),通氮氣攪拌30分鐘。接 著,加入總重之0.5重量%二月桂酸二丁基錫。6(rc油浴, 攪拌48小時後,以旋轉濃縮機濃縮,再以別艺真空烘箱 除去低揮發性物質。 例5 :眼科敷材或隱形眼鏡製作 將例3之含矽預聚物16.0重量%與甲基丙烯醯基氧丙 201239007 36950twf.doc/n 基三(三曱基矽氧烷基)矽烷(TRIS)18.0重量%、N,N•二曱 基丙烯醯胺(DMA) 22.0重量%、N-乙烯基D比嘻烧_(Ννρ) Π.5重量%、1-壬醇25.G重量%、乙二醇二曱基丙稀酸醋 0.5重|%以及2-說基-2-曱基-1-苯基-1·丙酉同(m3) 1 〇重 量%混合均勻,以約5mW/cm2 UVA進行聚合反應9〇分 鐘,再以酒精將未反應之單體與溶劑洗淨後,置於生理食 鹽水中靜置2小時,再以l21t:滅菌30分鐘。 < 例6 : —般外科敷材 將例4之改質含矽預聚物15·〇重量%與曱基丙烯醯氧 丙基二(二甲基石夕氧烧基)石夕烧19.0重量%、ν,Ν-二曱基丙 烯醯胺18.0重量%、Ν-乙烯基吡咯烷酮2〇〇重量3_ 曱基-1-戊醇27.0重量%以及偶氮二異丁腈(ΑΙΒΝ)1 〇重量 %混合均勻,於100°C進行聚合反應180分鐘,再以異丙 醇將未反應之單體與溶劑洗淨後,置於生理食趟水中 2小時,再以⑽滅菌3。分鐘。 "砰置 本發明例5所製得之眼科敷材或隱形眼鏡其透氧值 (DK)>50 ’可見光穿透度>90% ’含水量(%)>4〇 ;本發明例 6所製得之一般外科敷材其透氧值(DK)>3(),含水 (%)>30 ° 、綜上所述,本發明之含矽預聚物,其可做為聚矽酮水 ,膠之反應物,且所製得的聚矽明水凝膠具有高透氧性、 问牙透度、咼彈性與高保濕性,可以做為各種生物材料, 例如是隱形眼鏡、眼科紐、—般外科敷材(眼科以外之外 科敷材)或智慧型藥物敷材等等。 21 201239007 36950twf.doc/n 雖然本發明已以實施例揭露如上’然其並非用以限定 本發明,任何所屬技術領域t具有通常知識者, 本發明之精神和範_,#可作些許之更動與潤飾, 發明之保護範圍當視後附之申請專利範圍所界定者為準。 【圖式簡單說明】無 【主要元件符號說明】無 s 22Preferred are polyethylene glycol methyl ether isocyanate or polyvinyl pyrrolidone isocyanate. The above ruthenium-containing prepolymer can be reacted with other components to form various polyketone hydrogels. In the above method for producing a polyketone hydrogel, the above-mentioned ruthenium-containing prepolymer can be used as a reactant, and polymerization can be carried out by passing through an initiator, followed by curing. An appropriate amount of the poly-monomer-containing compound in the reaction mixture containing the above-mentioned cerium-containing prepolymer is used to effectively etch water, and the compatibility between the monomers is improved. In addition, optional further step-in-water monomer, cross-linking, diluent or combinations thereof may be optionally employed in the reaction mixture. The reaction mixture towel, the content of the (tetra) polymer and the polyaddition monomer is 5 to 99% by weight based on the total weight of the reaction, preferably 1 to 9 〇/6, more preferably 疋15 to 80% by weight. The weight ratio of the cerium-containing prepolymer to the polyorganism-containing monomer may be from 丨:G to 丨··99. The content of the hydrophilic monomer is from 5 to 9 % by weight based on the total weight of the mixture, preferably from 15 to 70% by weight, more preferably from 2 to 5 % by weight. The content of the cross-linking is 〇 to 5% by weight based on the total weight of the mixture, preferably (4) G to 3% by weight, and more preferably 0 to 2% by weight. The content of the diluent is 反应 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 2012 The content of the ketone monomer is in an embodiment, and the content of the yttrium-containing prepolymer and the amount of the hydrophilic monomer is 30% by weight. The amount is calculated. Straight 罝, with a reaction mixture of 100 weights. The above-mentioned poly- _ _ 盘 ^ 基 基 _ _ _ 氧 oxypropyl 1 prepolymer, including 3- 醯 醯 ethoxyethyl phenyl tetra? 2;$夕^基)石夕烧闺)' propyl bismuth oxide, methyl =, methacryloyloxymethylpentamethyl methacrylate _ oxygen ^ 3 = yl-n-pentyl fluorenyl Wei Shao, methyl three-stone oxy-oxygen, hyperthyroidism, 酼t, two dilute oxime oxyethyl triisopropyl tetra^ ^ propylene oxiranyl oxyethyl n-propyl octamethyl tetra oxime & 'methyl propyl _ Oxymethyl group II (trimethyl 醯 醯 某 某 某 & & & & & 丙烯 丙烯 丙烯 丙烯 丙烯 丙烯 丙烯 丙烯 丙烯 丙烯 丙烯 丙烯 丙烯 丙烯 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 The above hydrophilic monomer may be any hydrophilic monomer disclosed in the prior art for the manufacture of a hydrogel polymer. The hydrophilic monomer of the hydrogel biomaterial may be ethyl or propylene. The hydrophilic monomers include di-dimercaptopropylamine (DMA) and 2-ethylidene decyl acrylate (HEMA). ), glyceryl methacrylate, 2-hydroxyethyl decyl decylamine, N-vinyl pyrrolidone (NVP), polyethylene glycol methacrylate, methacrylic acid, acrylic acid or a combination thereof. According to the initiator of the polymerization reaction, the polymerization reaction can be induced by heating 17 201239007 36950twt.doc/n, or a combination thereof or other methods, for example, it can generate free radicals at medium and high temperatures, for example, Celsius to (9). For example, azobisisobutyronitrile (bronze), peroxidation, oxidized t-butyl pivalate, azobisisoheptyl, peroxidized twelfth or peroxidized (2-ethylhexanoic acid) Ding vinegar. #反应混合物 When the polymerization is carried out by ultraviolet light, the initiator can be a photoinducing initiator, including 2_ mercapto-2-methyl-1-phenyl-indole-acetone, double (2 , 4,6-trimethylbenzimidyl broad phenyl group, 1-hydroxycyclohexylphenylacetone, 2-(2,4,6-trimethylbenzylidene)diphenylphosphine oxide or 2,2-Dimethoxy-phenylacetamidine. Soil diluents include ethanol, 1-propanol, isopropanol, hydrazine-butanol, isobutanol, 2-butanol, 2-methyl-2. Propanol, 1-pentanol, 2-pentanol, 3-pentanol, 3-methylbutanol, 3-methyl-2-butanol '2-methyl-2-butanol, 2-methylbutyl Alcohol, = alcohol, 2-hexanol, 3-hexanol, 2-mercapto-1-pentanol, 3-mercapto-i-pentanol, 4-methyl-1-pentanol, 2-methyl-2-pentanol, 3-methyl-2-pentanol, 4-mercapto-2-pentanol, 2-methyl-3-pentanol, 3-methyl-3-pentanol, 3,3-dimercapto-i-butanol, 2-ethyl-1-butanol, i-heptanol, 2-heptanol, 3-heptanol, 4-heptanol, 1-octyl alcohol, 1- Sterol or a combination thereof. In addition to the above-mentioned hair-containing prepolymer, a microparticle-containing monomer, a starter, a hydrophilic monomer, and a diluent, it is used to produce the polysulfide g-gel of the present invention. The reaction mixture of the biomaterial may also include other monomers (such as ultraviolet absorbing monomers), reactive pigments, non-reactive pigments, or a combination thereof. In addition, a processing aid such as a release agent or a wetting agent may also be included in the reaction mixture. After the reaction was carried out to form a polymer, the diluent and the various components which were not reacted at 201239007 36950 twf.doc/n were removed, and the formed polymer was hydrated to form a hydrogel. The solvent used in the manufacture of the hydrogel may be water or physiological saline' or may be selected according to the solubility characteristics of the (iv) diluent and the solubility characteristics of various components which are not reacted when the polymer is produced, for example, Ethanol, decyl alcohol, isopropanol or a mixture of the foregoing solvents and a mixture of water or physiological saline is used to prepare a water-soluble polyoxanthene hydrogel. The water content in the poly(tetra) hydrogel is from 20 to 70% by weight, preferably from 25 to 50% by weight, more preferably from 30 to 50% by weight, based on the total weight of the polyhydric hydrogel. The above polyglycol hydrogel can be made into various biological materials, such as contact lenses, ophthalmic dressings, and general surgical dressings (external ophthalmology materials or smart type materials). Polyporous hydrogels can be used. The desired shape is formed by various known methods, such as a rotary molding method or a molding method. Example 1: Synthesis of a ruthenium-containing prepolymer ' 〇 5 '5 Mo's dihydrooxy polydimethyl Shixi oxygen plant (PDMS di〇1) was dehydrated with 4A molecular sieve for 24 hours. After that, the dihydrogen-polydimethyl oxazepine after water removal was placed in a four-well reaction flask and bitten with tetrahydrogen. Dilute 10 times. After the addition, add 0.4 moles of diisocyanate toluene and 〇2 mol methacrylic acid isocyanoacetic acid, stir for 3 minutes with nitrogen. Then, add the total weight 〇 5 wt% tin 2-ethylhexanoate. In a 6〇t oil bath, then, by rotating the concentrated silk (4), a yellowish (four) liquid is obtained. Read, and then vacuum oven to remove low volatile substances Example 2: Synthesis of ruthenium-containing prepolymer 3.3 moles of dihydroxy oxypolydimethyl oxazepine (PDMS_di〇1) was placed in four holes with 19 201239007 36950twf.doc/n &^, when the water is removed, the dihydro oxidized dimethyl sulphur, in the w bottle, and diluted 10 times with tetrahydrofuran. Thereafter, M_T diisocyanate 3 and G.2 mol methacrylic acid Isocyanide = 曰 3 gas stirring for 30 minutes. Then, add a total weight of 05 weight tin. Stir in a 6 叱 oil bath, 48 hours, and then spin to obtain a yellowish transparent liquid. After that, then vacuum at 5G ° C The oven removes low volatile substances. Example 3: Modification of the ruthenium-containing prepolymer Take the above, 2 shixi prepolymer 〇1 molar is placed in a four-well reaction flask, and the corpse is diluted with tetrahydrofuran. () times. After that, add _ Mo Er 2 gas 5 · (trifluoromethyl) phenyl isocyanate, stir for 3 minutes with nitrogen. Then, add the total weight of G. 5 wt% dilauric acid After the thief oil bath was mixed for 48 hours, it was concentrated by a rotary concentrator, and then 5 〇 < 3 (: vacuum drying off low volatility. " Example 4: 矽-containing prepolymer modification The ruthenium-containing prepolymer of the above Example 1 was placed in a four-well reaction flask at 0.005 mol, and diluted 10-fold with tetrahydrofuran. Thereafter, 〇〇〇5 mol polyethylene glycol methyl ether isocyanate (MW: ~) was added. 750), nitrogen gas After stirring for 30 minutes, a total weight of 0.5% by weight of dibutyltin dilaurate was added. 6 (rc oil bath, stirred for 48 hours, concentrated by a rotary concentrator, and then removed in a vacuum oven to remove low volatility. Example 5 : Ophthalmic dressing or contact lens preparation 16.0% by weight of the cerium-containing prepolymer of Example 3 and methacryl oxime oxypropyl 201239007 36950 twf.doc/n bis (tridecyl decyl oxyalkyl) decane (TRIS) 18.0 % by weight, N, N• dimercapto acrylamide (DMA) 22.0% by weight, N-vinyl D ratio 嘻 _ (Ννρ) Π. 5 wt%, 1-nonanol 25. G wt%, Ethylene Alcohol dimercaptoacetic acid vinegar 0.5%|% and 2-n-yl-2-mercapto-1-phenyl-1·propionium with (m3) 1 〇% by weight mixed uniformly, with about 5mW/cm2 UVA The polymerization reaction was carried out for 9 minutes, and the unreacted monomer and the solvent were washed with alcohol, and then allowed to stand in physiological saline for 2 hours, and then sterilized at 31 °C for 30 minutes. < Example 6: General Surgical Dressing The modified yttrium-containing prepolymer of Example 4 was 5% by weight and thiol propylene oxypropyl bis(dimethyl oxalate) %, ν, Ν-dimercapto acrylamide 18.0% by weight, Ν-vinyl pyrrolidone 2 〇〇 weight 3_ decyl-1-pentanol 27.0% by weight, and azobisisobutyronitrile (ΑΙΒΝ) 1 〇% by weight The mixture was uniformly mixed, and polymerization was carried out at 100 ° C for 180 minutes, and then the unreacted monomer and the solvent were washed with isopropyl alcohol, and then placed in physiological chyme water for 2 hours, and then sterilized by (10) 3. minute. "Oxygen permeability material or contact lens obtained in Example 5 of the present invention has an oxygen permeability value (DK) > 50 'visible light transmittance> 90% 'water content (%)> The general surgical dressing prepared in Example 6 has an oxygen permeability value (DK) > 3 (), water content (%) > 30 °, and in summary, the cerium-containing prepolymer of the present invention can be used as Polyfluorene ketone water, a gel reactant, and the obtained poly phthalocyanine hydrogel has high oxygen permeability, tooth permeability, enthalpy elasticity and high moisture retention, and can be used as various biological materials, such as contact lenses. , ophthalmology, general surgical dressing (external ophthalmology outside the ophthalmology) or intelligent drug dressings and so on. 21 201239007 36950twf.doc/n Although the present invention has been disclosed in the above embodiments, it is not intended to limit the present invention, and any technical field of the present invention has a general knowledge, and the spirit and scope of the present invention may be changed. Retouching, the scope of protection of the invention shall be subject to the definition of the scope of the patent application. [Simple diagram description] None [Main component symbol description] None s 22

Claims (1)

201239007 36950twf.doc/n 七、申請專利範圍: 1. 一種含矽預聚物,其結構如下式一所示: 【式一】 γ Y Γ I I 1 Z-X— E-X— C—N—A*— N— C—X— E-X—Z Tll II ^ Ο 0 m 其中 nl為1至20之整數; A表示二價脂肪族基團或芳香族基團; Y表示Η或是 十—Η —C=〇 全部的Y為完全相同或完全相異,或是部分Y相同且部分 Υ相異;Ry表示含氟之芳香族基團、含氟之醚基團、含醚 基團或含胺基之基團; X表示Ο或是-NRX-,Rx表示Η,或是碳數為1至5 之一價烧基,或 Η —C=〇 , 其中Ry之定義如上; 全部的Rx為完全相同或是完全相異,或是部分Rx相同且 部分Rx相異;以及 Z表示含烯基團。 23 201239007 36950twf.doc/n 2.如申請專利範圍第1項所述之含矽預聚物,其中: A所表示的一價脂肪族基團或芳香族基團的碳數為i 至20 ; E所表示一價梦氧烧基,其結構如下式二所示: 【式二】 一201239007 36950twf.doc/n VII. Patent application scope: 1. A cerium-containing prepolymer whose structure is as follows: [Formula 1] γ Y Γ II 1 ZX— EX— C—N—A*—N —C—X— EX—Z Tll II ^ Ο 0 m where nl is an integer from 1 to 20; A represents a divalent aliphatic group or an aromatic group; Y represents Η or Η—Η—C=〇 Y is completely the same or completely different, or part Y is the same and partially Υ is different; Ry represents a fluorine-containing aromatic group, a fluorine-containing ether group, an ether group or an amine group-containing group; X represents Ο or -NRX-, Rx represents Η, or a carbon number of 1 to 5, or Η - C = 〇, where Ry is as defined above; all Rx are identical or completely Iso, or part of Rx is the same and part of Rx is different; and Z represents an alkenyl group. 2. The cerium-containing prepolymer according to claim 1, wherein: the monovalent aliphatic group or the aromatic group represented by A has a carbon number of i to 20; E represents a monovalent dream oxygen base, and its structure is as shown in the following formula 2: [Formula 2] ——L—Q—Si—Ο——Si—Q—L-I ml Re2 Re2 其中Rel與Re2各自分別表示氫、碳數為1至5的一 價烧基、含氟取代基的烧基或基; Rel與Re2可以相同或是相異; m為0至40之整數; Q表示碳數為1至10之直鏈或支鏈之二價烧基; L表示單鍵、趟基或烧醇基; Z之結構如下式三所示: 【式三】- L - Q - Si - Ο - Si - Q - LI ml Re2 Re2 wherein Rel and Re2 each represent hydrogen, a monovalent alkyl group having a carbon number of 1 to 5, a flaming substituent or a group of a fluorine-containing substituent; Rel and Re2 may be the same or different; m is an integer from 0 to 40; Q represents a linear or branched divalent alkyl group having a carbon number of 1 to 10; and L represents a single bond, a fluorenyl group or an alkoxy group; The structure of Z is as shown in the following formula: [Formula 3] 丄-CH2CH2-〇4 /1 0 II /R2 -c—c 2 \ w ch2 其中Rz表示氫或是碳數為1至5之一價炫基;以及 n3表示〇至5之整數。 3·如申請專利範圍第1項所述之含矽預聚物,其中: L之結構如下所示 Λ ~fCnH2n〇^2 S 24 201239007 36950twf.doc/n 其中〇與Q鍵結;n為i至10之整數;以及n2為〇至2〇 之整數。 4二一種聚矽酮水凝膠之生物材料,其係由包含如申請 專利犯IS第1至3項巾任—獅述之切預聚物之反應混 &物I成,其中该反應混合物還包括起始劑,且選擇性更 進一步包括含聚矽酮單體、親水單體、稀釋劑或其組合。 5.如申請專利範圍第4項所述之聚矽酮水凝膠之生物 材料,其中該含矽預聚物與該含聚矽酮單體的重量比為 1 : 0 至 1 : 99。 ’ 如 T叫寻刊乾圍第4項所述之聚矽酮水凝膠之生物 材料,其中該含矽預聚物與該含聚矽_單體的I 重、該親水單體的含量為5至9〇重量%、該稀 釋劑的含1為0至80重量%以及該起始細含量為〇〇5 至5重量%,以該反應混合物為1〇〇重量%來計算。 7.如申請專利制第4項所述之聚糊水凝膠之生物 材料,其中該含聚_單體包括3_f基丙烯醯基氧丙基三 (二曱基魏絲)魏、丙稀醯氧乙基苯基四曱某二ς ==丙_氧甲基五甲基二石夕氧燒、甲基丙茲氧甲 ί 甲基三石夕氧烧、七Ψ基丙烯醯氧乙基三石夕氧 院、氧乙基三異丙基四甲基三魏烧、曱基丙稀酿 =乙基正丙基八甲基四魏炫、甲基_醯氧甲基甲 基石夕乳基)甲基德、_醯氧甲基三苯基 院、丙騎氧乙基苯基四乙基二錢院、丙烯醯 25 201239007 36950twf.doc/n 丁基六曱基三矽氧烷或丙烯醯氧乙基異丁基, 烷。 '、土 8. 如申請專利範圍第4項所述之聚㈣水凝膠之生物 材料,其中該親水單體包括Ν,Ν·二甲基丙婦酿胺①黯)、 2 -羥基乙基甲基丙烯酸_Μ Α)、甲基丙烯酸甘油酿、孓 羥基乙基甲丙烯醯胺、Ν_乙烯基吡咯烷酮(Ννρ)、聚 基丙烯酸乙二醇醋、甲基丙烯酸、丙稀酸或其組合。 9. 如申請專利範圍第4項所述之聚棚水凝膠之生 材料,其中該稀釋劑包括乙醇、i•丙醇、異丙醇、卜 異=、2: 丁醇、2_甲基_2_丙醇、1韻、2_戊醇、3_戊醇、 曱基丁醇、3_曱基_2_丁醇、2_甲基_2_丁醇、2_甲基、 己醇、3-己醇、2_甲基_1-戊醇、3_甲基+戊醇、 :甲严小戊醇、2·曱基-2-戊醇、3_甲基_2_戊醇、‘甲基_2_ 醇二2-曱基_3_戊醇、3_曱基小戊醇、3,3_二甲基+丁醇、 ,乙基·!·丁醇、庚醇、2_庚醇、3韻、 1-壬醇或其組合。 千0子 10. 如申請專利範圍第4項所述之 ==基)·笨基氧化膦、h經基環己基苯基丙_、2- (2,4 6_ ;甲基:甲醯基)二苯基氧化膦、2,2_二甲氧基-苯基乙酮、 異t異了腈、過氧料、過氧化新顧叔丁目旨、偶氮二 、庚晴、過氧化十二醯或過氧化(2•乙基己酸)叔丁醋。 S 物材十f專條^第4項所敎聚_水凝膠之生 勿材枓,係將該反應混合物照光或加熱聚合而成或其組合。 26 201239007 J6y3Utwt.doc/n 12.如申請專利範圍第4項所述之聚矽酮水凝膠之生 物材料為隱形眼鏡、眼科敷材、一般外科敷材或智慧型藥 物敷材。 27 201239007 36950twf.doc/n 个y ijj—Η —O. Ry is defined the same above. All Rx’s are identical or different. Or, some Rx,s are identical and some Rx’s are different. Z represents a group containing C-C double bond. 四、 指定代表圖: (一) 本案之指定代表圖:無 (二) 本代表圖之元件符號簡單說明:無 五、 本案若有化學式時,請揭示最能顯示發明特徵 的化學式: Y Y | | 1 ZxE—X--C一N—A—N—C——X—E——X—Z II || 0 0 n1丄-CH2CH2-〇4 /1 0 II /R2 -c-c 2 \ w ch2 wherein Rz represents hydrogen or a decyl group having a carbon number of 1 to 5; and n3 represents an integer of 〇 to 5. 3. The ruthenium-containing prepolymer as described in claim 1, wherein: the structure of L is as follows: f~fCnH2n〇^2 S 24 201239007 36950twf.doc/n where 〇 is bonded to Q; n is i An integer up to 10; and n2 is an integer from 〇 to 2〇. 4 a biomaterial of a polyfluorene ketone hydrogel, which comprises a reaction mixture and a substance I comprising a cut prepolymer as described in the patent application No. 1 to 3, wherein the reaction is The mixture also includes an initiator, and the selectivity further includes a polyfluorene containing monomer, a hydrophilic monomer, a diluent, or a combination thereof. 5. The biomaterial of the polyketone hydrogel of claim 4, wherein the weight ratio of the cerium-containing prepolymer to the polyfluorene-containing monomer is from 1:0 to 1:99. The biological material of the polyfluorene ketone hydrogel according to Item 4, wherein the content of the cerium-containing prepolymer and the poly-fluorene-containing monomer is 1. The content of the hydrophilic monomer is 5 to 9% by weight, the diluent contains 1 to 0 to 80% by weight, and the initial fine content is 〇〇5 to 5% by weight, calculated as 1% by weight of the reaction mixture. 7. The biomaterial of the poly-paste hydrogel according to the fourth aspect of the invention, wherein the poly-monomer comprises 3_f-based acryloyloxypropyl tris(di-decyl-Weiss) Wei, propylene Oxyethyl phenyl tetramethylene a certain hydrazine == propylene _ oxymethyl pentamethyl bismuth oxy-oxygen, methyl propyl oxymethyl ketone methyl celite oxy-oxygen, heptayl propylene oxy-oxyethyl three stone eve Oxygen, oxyethyltriisopropyltetramethyltricarb, thiopropyl propylene = ethyl n-propyl octamethyl tetraweix, methyl 醯 醯 甲基 甲基 ) ) ) Kidd, _ 醯 甲基 甲基 甲基 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 Isobutyl, alkane. The earth material of the poly(tetra) hydrogel according to the fourth aspect of the invention, wherein the hydrophilic monomer comprises hydrazine, dimethyl dimethyl aryl amine 1 黯), 2-hydroxyethyl Methacrylic acid Μ Α 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 孓 孓 孓 孓 乙烯基 乙烯基 乙烯基 乙烯基 乙烯基 乙烯基 乙烯基 乙烯基 乙烯基 乙烯基 乙烯基. 9. The raw material for a poly-hydrogel according to claim 4, wherein the diluent comprises ethanol, i. propanol, isopropanol, diiso =, 2: butanol, 2-methyl _2_propanol, 1 rhyme, 2_pentanol, 3-pentanol, mercaptobutanol, 3_mercapto-2-butanol, 2-methyl-2-butanol, 2-methyl, hexyl Alcohol, 3-hexanol, 2-methyl-1-pentanol, 3-methyl+pentanol, methylamine pentanol, 2-mercapto-2-pentanol, 3-methyl-2-pentyl Alcohol, 'methyl-2-alcohol di-2-mercapto-3-indolyl alcohol, 3-mercaptol pentanol, 3,3-dimethyl +butanol, ethyl·!·butanol, heptanol, 2_heptanol, 3 rhyme, 1-decyl alcohol or a combination thereof.千千子10. As stated in the scope of claim 4, == base)· stupyl phosphine oxide, h-cyclohexylphenyl propyl-, 2-(2,4 6_; methyl: methyl sulfhydryl) Diphenylphosphine oxide, 2,2-dimethoxy-phenyl ethyl ketone, iso-iso-nitrile, peroxygen, peroxidic neo-tert-butyl, azo, gamma, oxidized Or peroxidized (2•ethylhexanoic acid) tert-butyl vinegar. S material ten f special strip ^ item 4 敎 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 26 201239007 J6y3Utwt.doc/n 12. The biomaterial of the polyketone hydrogel as described in claim 4 is a contact lens, an ophthalmic dressing, a general surgical dressing or a smart drug dressing. 27 201239007 36950twf.doc/n y ijj—Η—O. Ry is defined the same above. All Rx's are identical or different. Or, some Rx,s are identical and some Rx's are different. Z represents a group containing CC double Bond. IV. Designated representative map: (1) Designated representative figure of the case: None (2) Simple description of the symbol of the representative figure: No. 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: YY | | 1 ZxE—X--C—N—A—N—C—X—E—X—Z II || 0 0 n1
TW100109561A 2011-03-21 2011-03-21 Silicon containing prepolymer and silicon-hydrogel organic material including the same TWI418573B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TW100109561A TWI418573B (en) 2011-03-21 2011-03-21 Silicon containing prepolymer and silicon-hydrogel organic material including the same
CN201210044457.3A CN102690419B (en) 2011-03-21 2012-02-24 Silicon-containing prepolymer and silicone hydrogel biomaterial containing same
KR1020120026547A KR101410005B1 (en) 2011-03-21 2012-03-15 Silicon containing prepolymer and silicon-hydrogel organic material including the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW100109561A TWI418573B (en) 2011-03-21 2011-03-21 Silicon containing prepolymer and silicon-hydrogel organic material including the same

Publications (2)

Publication Number Publication Date
TW201239007A true TW201239007A (en) 2012-10-01
TWI418573B TWI418573B (en) 2013-12-11

Family

ID=46856167

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100109561A TWI418573B (en) 2011-03-21 2011-03-21 Silicon containing prepolymer and silicon-hydrogel organic material including the same

Country Status (3)

Country Link
KR (1) KR101410005B1 (en)
CN (1) CN102690419B (en)
TW (1) TWI418573B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6715071B2 (en) * 2016-04-27 2020-07-01 信越化学工業株式会社 Hydrolysis-resistant silicone compound and method for producing the same
JP2020097603A (en) * 2020-01-31 2020-06-25 信越化学工業株式会社 Hydrolysis resistant silicone compound and manufacturing method therefor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60146219A (en) * 1984-01-11 1985-08-01 Toray Ind Inc Contact lens
KR100468803B1 (en) * 1995-12-07 2005-04-19 바슈 앤드 롬 인코포레이티드 Monomer units useful for reducing the modulus of silicone hydrogels
US7052131B2 (en) * 2001-09-10 2006-05-30 J&J Vision Care, Inc. Biomedical devices containing internal wetting agents
US7368589B2 (en) * 2003-10-31 2008-05-06 Johnson & Johnson Vision Care, Inc. Purification of silicone containing compounds by supercritical fluid extraction
US7786185B2 (en) * 2004-03-05 2010-08-31 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising acyclic polyamides
US20090295004A1 (en) * 2008-06-02 2009-12-03 Pinsly Jeremy B Silicone hydrogel contact lenses displaying reduced protein uptake
US20100078837A1 (en) * 2008-09-29 2010-04-01 Pugh Randall B Apparatus and method for formation of an energized ophthalmic device

Also Published As

Publication number Publication date
CN102690419A (en) 2012-09-26
CN102690419B (en) 2014-05-07
KR20120107435A (en) 2012-10-02
TWI418573B (en) 2013-12-11
KR101410005B1 (en) 2014-06-20

Similar Documents

Publication Publication Date Title
US9523793B2 (en) Composition for manufacturing contact lenses and method for manufacturing contact lenses by using the same
TW510910B (en) Silicone hydrogel polymers and soft contact lenses comprising them
TWI248446B (en) Optically transparent hydrogels and processes for their production
TWI363069B (en)
JP5529958B2 (en) Biomedical device, polymer material and contact lens including the same
JP3490436B2 (en) Novel UV-curable crosslinker useful in copolymerization
CN103547585B (en) Siloxanyl monomers, its preparation method and the thin film comprising it for contact lens application containing hydrolytic resistance carbon siloxanes linker
US7279538B2 (en) Aromatic-based polysiloxane prepolymers and ophthalmic devices produced therefrom
US20120245249A1 (en) Siloxane monomers containing hydrolysis resistance carbosiloxane linkage, process for their preparation and thin films containing the same for contact lens application
JP2003268055A (en) Surface wettable silicone hydrogel
JPH08506841A (en) Fluorosilicone hydrogel
JP6236059B2 (en) Hydrophilic macromer and hydrogel containing the same
JP2003505728A (en) Contact lens material
CN101421335A (en) Cationic end-capped siloxane prepolymer for reduced cross-link density
US9296764B2 (en) Hydrophilic silicone composition
JP2015516998A (en) Hydrophilic silicone monomer, its preparation process and thin film containing it
CN107531847A (en) Hydrophile copolymers based on organosilicon and include its hydrogel composition
JP2016079298A (en) Radical polymerizable group-containing silicone compound and production method of the same
JP2012520353A (en) Monomers and macromers for forming hydrogels
EP2828692B1 (en) Hydrophilic macromers and hydrogels comprising the same
TW201239007A (en) Silicon containing prepolymer and silicon-hydrogel organic material including the same
JP2015515514A5 (en)
US8030423B2 (en) Multi-armed macromonomers
TW202323337A (en) Dimethicone-containing monomers having phosphorylcholine and hydroxyl groups
TWI311580B (en) Biomedical devices containing internal wetting agents

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees